A Low‐Cost Durable Na‐FeCl2 Battery with Ultrahigh Rate Capability

Na‐based batteries have long been regarded as an inexpensive, sustainable candidate for large‐scale stationary energy storage applications. Unfortunately, the market penetration of conventional Na‐NiCl₂ batteries is approaching its limit for several reasons, including limited rate capability and high Ni cost. Herein, a Na‐FeCl₂ battery operating at 190 °C is reported that allows a capacity output of 116 mAh g^?1 at an extremely high current density of 33.3 mA cm^?2 (≈0.6C). The superior rate performance is rooted in the intrinsically fast kinetics of the Fe/Fe²⁺ redox reaction. Furthermore, it is demonstrated that a small amount of Ni additive (10 mol%) effectively mitigates capacity fading of the Fe/NaCl cathode caused by Fe particle pulverization during long‐term cycling. The modified Fe/Ni cathode exhibits excellent cycling stability, maintaining a discharge energy density of over 295 Wh kg^?1 for 200 cycles at 10 mA cm^?2 (≈C/5).     

Moderate Intensity Static Magnetic Fields Prevent Thrombus Formation in Rats and Mice

We established three types of thrombosis models to explore the effects of the static magnetic field (SMF) on thrombosis in rats and mice with three different MF intensities. In the carrageenan-induced thrombosis model in rats, the SMF treatments reduced the black tail length of rats, extracorporeal thrombus, and the mass of wet and dry thrombus, and improved the coagulation index value. In FeCl₃-induced arterial thrombosis model in rats, the SMF treatment showed some anti-thrombotic effects. More specifically, the SMF treatment affected rodent blood pressure, plasma plasminogen activator inhibitor, tissue-type plasminogen activator, thrombus mass, and thrombus protein content. In the adrenaline-induced thrombosis model in mice, the SMF treatment had certain effects on the diameter and blood flow velocity of mouse auricle microcirculation in fine veins and arteries. Overall, the highest MF intensities we tested, 20–150 mT, showed a trend of anti-thrombotic effect, indicating that the moderate-intensity SMF might serve as a potential treatment for clot-related diseases in the future. Bioelectromagnetics. 2020;41:52–62 © 2019 Bioelectromagnetics Society.     

非特异性DNA的催化活性(Ⅰ)──应用酚试剂及FeCl_3检测DNA的酯酶活性

分别应用酚试剂与ＦｅＣｌ３来检测萘酚,表明ＤＮＡ能催化乙酸萘酯的水解,印证了以前关于ＤＮＡ具有酯酶活性的结论．ＦｅＣｌ３法可以作为检测ＤＮＡ酯酶活性的一种定量方法．